Sign in

CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company

Tonix Pharmaceuticals Holding Corp.

Sign in to watch
Ticker
TNXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
261434750
Phone
212-980-9155
Business address
200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
Former names
TAMANDARE EXPLORATIONS INC.
Open-market buys, last 90 days
$60,455
in 3 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. LEDERMAN SETH +$48K Chief Executive Officer 2 filings
  2. BAGGER RICHARD H +$13K Director 1 filing
Date Insider Transaction Shares Price Value Owned after
2020-02-25 SAENGER BRADLEY Chief Financial Officer Grant or award · Stock Option +24,000 24,000
2020-02-25 SAENGER BRADLEY Chief Financial Officer Grant or award · Stock Option +24,000 24,000
2020-02-25 SULLIVAN GREGORY M Chief Medical Officer Grant or award · Stock Option +39,000 39,000
2020-02-25 SULLIVAN GREGORY M Chief Medical Officer Grant or award · Stock Option +39,000 39,000
2020-02-25 LEDERMAN SETH Chief Executive Officer Grant or award · Stock Option +120,000 120,000
2020-02-25 LEDERMAN SETH Chief Executive Officer Grant or award · Stock Option +120,000 120,000
2020-02-25 MORRIS JESSICA EDGAR Chief Operating Officer Grant or award · Stock Option +24,000 24,000
2020-02-25 MORRIS JESSICA EDGAR Chief Operating Officer Grant or award · Stock Option +24,000 24,000
2019-12-03 LEDERMAN SETH Chief Executive Officer Purchase +20,000 $1.16 $23K 23,267
2019-05-06 Goodman Daniel Wintner Director Grant or award · Stock Option +30,000 30,000
2019-05-06 LEDERMAN SETH Chief Executive Officer Grant or award · Stock Option +129,758 129,758
2019-05-06 LEDERMAN SETH Chief Executive Officer Grant or award · Stock Option +129,757 129,757
2019-05-06 SULLIVAN GREGORY M Chief Medical Officer Grant or award · Stock Option +43,253 43,253
2019-05-06 SULLIVAN GREGORY M Chief Medical Officer Grant or award · Stock Option +43,252 43,252
2019-05-06 SAENGER BRADLEY Chief Financial Officer Grant or award · Stock Option +28,835 28,835
2019-05-06 SAENGER BRADLEY Chief Financial Officer Grant or award · Stock Option +28,835 28,835
2019-05-06 MORRIS JESSICA EDGAR Chief Operating Officer Grant or award · Stock Option +28,835 28,835
2019-05-06 MORRIS JESSICA EDGAR Chief Operating Officer Grant or award · Stock Option +28,835 28,835
2019-05-06 LANDRY DONALD W Director Grant or award · Stock Option +30,000 30,000
2019-05-06 GRANGE DAVID L Director Grant or award · Stock Option +30,000 30,000

Page 9 of 25 · 482 trades